 - Arm I delayed ADT: Beginning at least 2 years after study entry or after exhibiting evidence of significant disease progression, patients receive either continuous ADT OR intermittent ADT comprising either bilateral orchiectomy OR luteinizing hormone-releasing hormone agonist with or without oral antiandrogen therapy. 